Market Analysis and Insights: Global and United States Gene Therapy Medicinal Products (GTMP) Market
This report focuses on global and United States Gene Therapy Medicinal Products (GTMP) market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Gene Therapy Medicinal Products (GTMP) market size is estimated to be worth US$ million in 2025 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Oral accounting for % of the Gene Therapy Medicinal Products (GTMP) global market in 2025, is projected to value US$ million by 2031, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Cancer was the leading segment, accounting for over percent market share in 2025, and altered to an % CAGR throughout this forecast period.
In United States the Gene Therapy Medicinal Products (GTMP) market size is expected to grow from US$ million in 2025 to US$ million by 2031, at a CAGR of % during the forecast period.
Global Gene Therapy Medicinal Products (GTMP) Scope and Market Size
Gene Therapy Medicinal Products (GTMP) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Gene Therapy Medicinal Products (GTMP) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2025-2031.
For United States market, this report focuses on the Gene Therapy Medicinal Products (GTMP) market size by players, by Type and by Application, for the period 2025-2031. The key players include the global and local players, which play important roles in United States.
Segment by Type
Oral
Injection
Segment by Application
Cancer
Monogenic
Infectious Disease
Cardiovascular Disease
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
1 Study Coverage
1.1 Gene Therapy Medicinal Products (GTMP) Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025) & (US$ Million) Introduction
1.2 Global Gene Therapy Medicinal Products (GTMP) Outlook 2021 VS 2025 VS 2031
1.2.1 Global Gene Therapy Medicinal Products (GTMP) Market Size for the Year 2025-2031
1.2.2 Global Gene Therapy Medicinal Products (GTMP) Market Size for the Year 2025-2031
1.3 Gene Therapy Medicinal Products (GTMP) Market Size, United States VS Global, 2021 VS 2025 VS 2031
1.3.1 The Market Share of United States Gene Therapy Medicinal Products (GTMP) in Global, 2021 VS 2025 VS 2031
1.3.2 The Growth Rate of Gene Therapy Medicinal Products (GTMP) Market Size, United States VS Global, 2021 VS 2025 VS 2031
1.4 Gene Therapy Medicinal Products (GTMP) Market Dynamics
1.4.1 Gene Therapy Medicinal Products (GTMP) Industry Trends
1.4.2 Gene Therapy Medicinal Products (GTMP) Market Drivers
1.4.3 Gene Therapy Medicinal Products (GTMP) Market Challenges
1.4.4 Gene Therapy Medicinal Products (GTMP) Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Gene Therapy Medicinal Products (GTMP) by Type
2.1 Gene Therapy Medicinal Products (GTMP) Market Segment by Type
2.1.1 Oral
2.1.2 Injection
2.2 Global Gene Therapy Medicinal Products (GTMP) Market Size by Type (2021, 2025 & 2031)
2.3 Global Gene Therapy Medicinal Products (GTMP) Market Size by Type (2025-2031)
2.4 United States Gene Therapy Medicinal Products (GTMP) Market Size by Type (2021, 2025 & 2031)
2.5 United States Gene Therapy Medicinal Products (GTMP) Market Size by Type (2025-2031)
3 Gene Therapy Medicinal Products (GTMP) by Application
3.1 Gene Therapy Medicinal Products (GTMP) Market Segment by Application
3.1.1 Cancer
3.1.2 Monogenic
3.1.3 Infectious Disease
3.1.4 Cardiovascular Disease
3.1.5 Other
3.2 Global Gene Therapy Medicinal Products (GTMP) Market Size by Application (2021, 2025 & 2031)
3.3 Global Gene Therapy Medicinal Products (GTMP) Market Size by Application (2025-2031)
3.4 United States Gene Therapy Medicinal Products (GTMP) Market Size by Application (2021, 2025 & 2031)
3.5 United States Gene Therapy Medicinal Products (GTMP) Market Size by Application (2025-2031)
4 Global Gene Therapy Medicinal Products (GTMP) Competitor Landscape by Company
4.1 Global Gene Therapy Medicinal Products (GTMP) Market Size by Company
4.1.1 Top Global Gene Therapy Medicinal Products (GTMP) Companies Ranked by Revenue (2025)
4.1.2 Global Gene Therapy Medicinal Products (GTMP) Revenue by Player (2021-2025)
4.2 Global Gene Therapy Medicinal Products (GTMP) Concentration Ratio (CR)
4.2.1 Gene Therapy Medicinal Products (GTMP) Market Concentration Ratio (CR) (2021-2025)
4.2.2 Global Top 5 and Top 10 Largest Companies of Gene Therapy Medicinal Products (GTMP) in 2021
4.2.3 Global Gene Therapy Medicinal Products (GTMP) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Gene Therapy Medicinal Products (GTMP) Headquarters, Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025) & (US$ Million) Type
4.3.1 Global Gene Therapy Medicinal Products (GTMP) Headquarters and Area Served
4.3.2 Global Gene Therapy Medicinal Products (GTMP) Companies Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Gene Therapy Medicinal Products (GTMP) Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Gene Therapy Medicinal Products (GTMP) Market Size by Company
4.5.1 Top Gene Therapy Medicinal Products (GTMP) Players in United States, Ranked by Revenue (2025)
4.5.2 United States Gene Therapy Medicinal Products (GTMP) Revenue by Players (2023, 2024 & 2025)
5 Global Gene Therapy Medicinal Products (GTMP) Market Size by Region
5.1 Global Gene Therapy Medicinal Products (GTMP) Market Size by Region: 2021 VS 2025 VS 2031
5.2 Global Gene Therapy Medicinal Products (GTMP) Market Size by Region (2025-2031)
5.2.1 Global Gene Therapy Medicinal Products (GTMP) Market Size by Region: 2021-2025
5.2.2 Global Gene Therapy Medicinal Products (GTMP) Market Size by Region (2025-2031)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth 2025-2031
6.1.2 North America Gene Therapy Medicinal Products (GTMP) Market Facts & Figures by Country (2021, 2025 & 2031)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth 2025-2031
6.2.2 Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Facts & Figures by Region (2021, 2025 & 2031)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth 2025-2031
6.3.2 Europe Gene Therapy Medicinal Products (GTMP) Market Facts & Figures by Country (2021, 2025 & 2031)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth 2025-2031
6.4.2 Latin America Gene Therapy Medicinal Products (GTMP) Market Facts & Figures by Country (2021, 2025 & 2031)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Gene Therapy Medicinal Products (GTMP) Market Size YoY Growth 2025-2031
6.5.2 Middle East and Africa Gene Therapy Medicinal Products (GTMP) Market Facts & Figures by Country (2021, 2025 & 2031)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Bluebird Bio
7.1.1 Bluebird Bio Company Details
7.1.2 Bluebird Bio Business Overview
7.1.3 Bluebird Bio Gene Therapy Medicinal Products (GTMP) Introduction
7.1.4 Bluebird Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025)
7.1.5 Bluebird Bio Recent Development
7.2 Sangamo
7.2.1 Sangamo Company Details
7.2.2 Sangamo Business Overview
7.2.3 Sangamo Gene Therapy Medicinal Products (GTMP) Introduction
7.2.4 Sangamo Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025)
7.2.5 Sangamo Recent Development
7.3 Spark Therapeutics
7.3.1 Spark Therapeutics Company Details
7.3.2 Spark Therapeutics Business Overview
7.3.3 Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Introduction
7.3.4 Spark Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025)
7.3.5 Spark Therapeutics Recent Development
7.4 Dimension Therapeutics
7.4.1 Dimension Therapeutics Company Details
7.4.2 Dimension Therapeutics Business Overview
7.4.3 Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Introduction
7.4.4 Dimension Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025)
7.4.5 Dimension Therapeutics Recent Development
7.5 Avalanche Bio
7.5.1 Avalanche Bio Company Details
7.5.2 Avalanche Bio Business Overview
7.5.3 Avalanche Bio Gene Therapy Medicinal Products (GTMP) Introduction
7.5.4 Avalanche Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025)
7.5.5 Avalanche Bio Recent Development
7.6 Celladon
7.6.1 Celladon Company Details
7.6.2 Celladon Business Overview
7.6.3 Celladon Gene Therapy Medicinal Products (GTMP) Introduction
7.6.4 Celladon Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025)
7.6.5 Celladon Recent Development
7.7 Vical Inc.
7.7.1 Vical Inc. Company Details
7.7.2 Vical Inc. Business Overview
7.7.3 Vical Inc. Gene Therapy Medicinal Products (GTMP) Introduction
7.7.4 Vical Inc. Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025)
7.7.5 Vical Inc. Recent Development
7.8 Advantagene
7.8.1 Advantagene Company Details
7.8.2 Advantagene Business Overview
7.8.3 Advantagene Gene Therapy Medicinal Products (GTMP) Introduction
7.8.4 Advantagene Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025)
7.8.5 Advantagene Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Gene Therapy Medicinal Products (GTMP) Market Size United States VS Global, CAGR (2021 VS 2025 VS 2031)
Table 2. Gene Therapy Medicinal Products (GTMP) Market Trends
Table 3. Gene Therapy Medicinal Products (GTMP) Market Drivers
Table 4. Gene Therapy Medicinal Products (GTMP) Market Challenges
Table 5. Gene Therapy Medicinal Products (GTMP) Market Restraints
Table 6. Global Gene Therapy Medicinal Products (GTMP) Market Size by Type: 2021 VS 2025 VS 2031 (US$ Million)
Table 7. United States Gene Therapy Medicinal Products (GTMP) Market Size by Type: 2021 VS 2025 VS 2031 (US$ Million)
Table 8. Global Gene Therapy Medicinal Products (GTMP) Market Size by Application: 2021 VS 2025 VS 2031 (US$ Million)
Table 9. United States Gene Therapy Medicinal Products (GTMP) Market Size by Application: 2021 VS 2025 VS 2031 (US$ Million)
Table 10. Top Gene Therapy Medicinal Products (GTMP) Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Gene Therapy Medicinal Products (GTMP) Revenue by Player, (US$ Million), 2021-2025
Table 12. Global Gene Therapy Medicinal Products (GTMP) Revenue Share by Player, 2021-2025
Table 13. Global Gene Therapy Medicinal Products (GTMP) Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gene Therapy Medicinal Products (GTMP) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Medicinal Products (GTMP) as of 2021)
Table 15. Top Players of Gene Therapy Medicinal Products (GTMP) in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025) & (US$ Million) Type
Table 17. Date of International Companies Enter into Gene Therapy Medicinal Products (GTMP) Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Gene Therapy Medicinal Products (GTMP) Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Gene Therapy Medicinal Products (GTMP) Revenue by Players, (US$ Million), 2023, 2024 & 2025
Table 21. United States Gene Therapy Medicinal Products (GTMP) Revenue Share by Players, 2023, 2024 & 2025
Table 22. Global Gene Therapy Medicinal Products (GTMP) Market Size by Region (US$ Million): 2021 VS 2025 VS 2031
Table 23. Global Gene Therapy Medicinal Products (GTMP) Market Size by Region (2021-2025) & (US$ Million)
Table 24. Global Gene Therapy Medicinal Products (GTMP) Market Size Forecast by Region (2025-2031) & (US$ Million)
Table 25. North America Gene Therapy Medicinal Products (GTMP) Sales in Value by Country (2025-2031) & (US$ Million)
Table 26. Asia Pacific Gene Therapy Medicinal Products (GTMP) Sales in Value by Region (2025-2031) & (US$ Million)
Table 27. Europe Gene Therapy Medicinal Products (GTMP) Sales in Value by Country (2025-2031) & (US$ Million)
Table 28. Latin Americaa Gene Therapy Medicinal Products (GTMP) Sales in Value by Country (2025-2031) & (US$ Million)
Table 29. Middle East and Africa Gene Therapy Medicinal Products (GTMP) Sales in Value by Country (2025-2031) & (US$ Million)
Table 30. Bluebird Bio Company Details
Table 31. Bluebird Bio Business Overview
Table 32. Bluebird Bio Gene Therapy Medicinal Products (GTMP) Product
Table 33. Bluebird Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025) & (US$ Million)
Table 34. Bluebird Bio Recent Development
Table 35. Sangamo Company Details
Table 36. Sangamo Business Overview
Table 37. Sangamo Gene Therapy Medicinal Products (GTMP) Product
Table 38. Sangamo Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025) & (US$ Million)
Table 39. Sangamo Recent Development
Table 40. Spark Therapeutics Company Details
Table 41. Spark Therapeutics Business Overview
Table 42. Spark Therapeutics Gene Therapy Medicinal Products (GTMP) Product
Table 43. Spark Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025) & (US$ Million)
Table 44. Spark Therapeutics Recent Development
Table 45. Dimension Therapeutics Company Details
Table 46. Dimension Therapeutics Business Overview
Table 47. Dimension Therapeutics Gene Therapy Medicinal Products (GTMP) Product
Table 48. Dimension Therapeutics Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025) & (US$ Million)
Table 49. Dimension Therapeutics Recent Development
Table 50. Avalanche Bio Company Details
Table 51. Avalanche Bio Business Overview
Table 52. Avalanche Bio Gene Therapy Medicinal Products (GTMP) Product
Table 53. Avalanche Bio Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025) & (US$ Million)
Table 54. Avalanche Bio Recent Development
Table 55. Celladon Company Details
Table 56. Celladon Business Overview
Table 57. Celladon Gene Therapy Medicinal Products (GTMP) Product
Table 58. Celladon Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025) & (US$ Million)
Table 59. Celladon Recent Development
Table 60. Vical Inc. Company Details
Table 61. Vical Inc. Business Overview
Table 62. Vical Inc. Gene Therapy Medicinal Products (GTMP) Product
Table 63. Vical Inc. Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025) & (US$ Million)
Table 64. Vical Inc. Recent Development
Table 65. Advantagene Company Details
Table 66. Advantagene Business Overview
Table 67. Advantagene Gene Therapy Medicinal Products (GTMP) Product
Table 68. Advantagene Revenue in Gene Therapy Medicinal Products (GTMP) Business (2021-2025) & (US$ Million)
Table 69. Advantagene Recent Development
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Therapy Medicinal Products (GTMP) Product Picture
Figure 2. Global Gene Therapy Medicinal Products (GTMP) Market Size, (US$ Million), 2021 VS 2025 VS 2031
Figure 3. Global Gene Therapy Medicinal Products (GTMP) Market Size 2025-2031 (US$ Million)
Figure 4. United States Gene Therapy Medicinal Products (GTMP) Market Size, (US$ Million), 2021 VS 2025 VS 2031
Figure 5. United States Gene Therapy Medicinal Products (GTMP) Market Size 2025-2031 (US$ Million)
Figure 6. United States Gene Therapy Medicinal Products (GTMP) Market Share in Global 2025-2031
Figure 7. Gene Therapy Medicinal Products (GTMP) Report Years Considered
Figure 8. Product Picture of Oral
Figure 9. Product Picture of Injection
Figure 10. Global Gene Therapy Medicinal Products (GTMP) Market Share by Type in 2025 & 2031
Figure 11. Global Gene Therapy Medicinal Products (GTMP) Market Size by Type (2025-2031) & (US$ Million)
Figure 12. Global Gene Therapy Medicinal Products (GTMP) Market Share by Type (2025-2031)
Figure 13. United States Gene Therapy Medicinal Products (GTMP) Market Share by Type in 2025 & 2031
Figure 14. United States Gene Therapy Medicinal Products (GTMP) Market Size by Type (2025-2031) & (US$ Million)
Figure 15. United States Gene Therapy Medicinal Products (GTMP) Market Share by Type (2025-2031)
Figure 16. Product Picture of Cancer
Figure 17. Product Picture of Monogenic
Figure 18. Product Picture of Infectious Disease
Figure 19. Product Picture of Cardiovascular Disease
Figure 20. Product Picture of Other
Figure 21. Global Gene Therapy Medicinal Products (GTMP) Market Share by Application in 2025 & 2031
Figure 22. Global Gene Therapy Medicinal Products (GTMP) Market Size by Application (2025-2031) & (US$ Million)
Figure 23. Global Gene Therapy Medicinal Products (GTMP) Market Share by Application (2025-2031)
Figure 24. United States Gene Therapy Medicinal Products (GTMP) Market Share by Application in 2025 & 2031
Figure 25. United States Gene Therapy Medicinal Products (GTMP) Market Size by Application (2025-2031) & (US$ Million)
Figure 26. United States Gene Therapy Medicinal Products (GTMP) Market Share by Application (2025-2031)
Figure 27. North America Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate 2025-2031 (US$ Million)
Figure 28. United States Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 29. Canada Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 30. Europe Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate 2025-2031 (US$ Million)
Figure 31. Germany Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 32. France Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 33. U.K. Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 34. Italy Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 35. Russia Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 36. Asia-Pacific Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate 2025-2031 (US$ Million)
Figure 37. China Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 38. Japan Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 39. South Korea Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 40. India Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 41. Australia Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 42. China Taiwan Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 43. Indonesia Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 44. Thailand Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 45. Malaysia Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 46. Latin America Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate 2025-2031 (US$ Million)
Figure 47. Mexico Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 48. Brazil Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 49. Argentina Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 50. Middle East & Africa Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate 2025-2031 (US$ Million)
Figure 51. Turkey Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 52. Saudi Arabia Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 53. UAE Gene Therapy Medicinal Products (GTMP) Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 54. Bluebird Bio Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2021-2025)
Figure 55. Sangamo Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2021-2025)
Figure 56. Spark Therapeutics Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2021-2025)
Figure 57. Dimension Therapeutics Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2021-2025)
Figure 58. Avalanche Bio Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2021-2025)
Figure 59. Celladon Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2021-2025)
Figure 60. Vical Inc. Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2021-2025)
Figure 61. Advantagene Revenue Growth Rate in Gene Therapy Medicinal Products (GTMP) Business (2021-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:
Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.
Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.
Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.
Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.